DEXCOM INC — Director's Dealing 2015

Aug 19, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2015-08-17

Reporting Person: GREGG TERRANCE H (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-18	Common Stock	M	28392.0	$6.85	Acquired	459018	Direct
2015-08-17	Common Stock	S	15000.0	$96.7146	Disposed	366389	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-08-18	Incentive Stock Option (right to buy)	$6.85	M	28392.0	Disposed	2017-06-19	Common Stock (28392)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	11461	Indirect

Footnotes

F1: Included in this number are 167,032 unvested restricted stock units, 35,000 of which were granted on March 8, 2015 and will vest on March 8, 2016, 96,485 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017, and 35,547 unvested restricted stock units granted on March 11, 2013, 5,078 of which shall vest each month through March 11, 2016.

F2: On December 12, 2014, Mr. Gregg adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F3: This transaction was executed in multiple trades at prices ranging from $95.27 to $98.32. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F4: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.